This study involves one in-person visit to Vanderbilt University Medical Center for a single blood draw and urine collection. Participants will be compensated for their time. The purpose of this study is to measure a metabolite called α-aminoadipic acid (2-AAA) in blood. Different amounts of 2-AAA in the body may alter the risk of developing diabetes. We are interested in whether 2-AAA is present at different levels in healthy people.
You may qualify if you:
- Ages 18 – 45
- BMI 18 to <30 kg/m2
- Omnivorous and do not follow any restricted diet or have food allergies
- Do not currently use tobacco products or have not done so in the past 30 days
- Do not currently use any prescription medications (except hormonal birth control)
- Do not currently use lysine supplements or are willing to temporarily discontinue use
- Do not have any history of cardiovascular disease, renal disease, or liver disease
- Do not have diabetes mellitus
- Do not have atrial fibrillation
- Do not have a bleeding disorder or anemia
- Are not pregnant or lactating
- Have not participated in another clinical trial in the past 6 weeks
- Able to participate in follow up studies
- Able to fast for 8 hours
To find out if you are eligible for this project, please copy and paste the following link into your internet browser to complete a screening survey: https://redcap.vanderbilt.edu/surveys/?s=KWD7JTTFJC
A member of the study team will be in touch once the survey is submitted.